4//SEC Filing
ASELAGE STEVE 4
Accession 0001127602-22-016409
CIK 0000882796other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:43 PM ET
Size
4.5 KB
Accession
0001127602-22-016409
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Common Stock
2022-05-31$9.31/sh+569$5,297→ 33,728 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250, prorated to $10,597.83 based on the increase in the annual retainer fee effective April 18, 2022.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001221599
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:43 PM ET
- Size
- 4.5 KB